41554 blogs · 4,417,066 posts Claim your blog

Record · corpus.blog/posts/01a08765-a0ef-71e2-8b01-5b8e12b72a03

SAB-142 From SAb Biotherapeutics Starts a Phase II Trial (SAFEGUARD)

cureresearch4type1diabetes.blogspot.com · published 16 June 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at cureresearch4type1diabetes.blogspot.com Wayback capture

0blogs citing

First cited: —
Most recent: —
Rank this month: not ranked
Links from this post: 10
Words captured: 1,472

Cited by

No blog we hold has cited this post yet.

Links from this post

Link

Host

https://clinicaltrials.gov/study/NCT07187531

clinicaltrials.gov

https://ir.sab.bio/static-files/d6f0e78d-2429-4f5f-97e1-0b3b930f8c3c

ir.sab.bio

https://safeguardstudy.com/

safeguardstudy.com

https://www.sab.bio

sab.bio

https://ir.sab.bio/news-releases/news-release-details/first-patient-dosed-sab-bios-safeguard-clinical-trial-sab-142

ir.sab.bio

https://www.globenewswire.com/news-release/2026/04/22/

globenewswire.com

https://www.breakthrought1d.org.au/research/clinical-trials/

breakthrought1d.org.au

https://t1dfund.org/news/fda-provides-clearance-to-ind-application-for-type-1-diabetes-therapy-sab-142-by-sab-biotherapeutics/

t1dfund.org

https://pubmed.ncbi.nlm.nih.gov/40976248/

pubmed.ncbi.nlm.nih.gov

https://pmc.ncbi.nlm.nih.gov/articles/PMC8173803/

pmc.ncbi.nlm.nih.gov